Prestige Biopharma and Dr. Reddy’s push Herceptin biosimilar into Brazil
Prestige Biopharma is betting on Brazil as its gateway into Latin America’s biosimilar market. The Korean biosimilar developer said Tuesday that its partner, Dr. Reddy’s Laboratories, has submitted a marketing authorization application for Tuznue, its …